Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Callery

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
Journal of the American College of Surgeons|September 1, 2009
Diagnosis and management of pancreatic pseudocysts: what is the evidence?Jeremy W Cannon, Mark P Callery, Charles M Vollmer
Surgical Oncology|November 24, 2001
Ubiquitin proteasome pathway: implications and advances in cancer therapyS A Shah, M W Potter, M P Callery
Surgery|June 21, 2002
Ubiquitin proteasome inhibition and cancer therapyShimul A Shah, Michael W Potter, Mark P Callery
Surgical Laparoscopy & Endoscopy|April 1, 1996
Strangulated incisional hernia at trocar siteD B Jones, M P Callery, N J Soper
Surgery|August 1, 1991
A biologic basis for limited Kupffer cell reactivity to portal-derived endotoxinM P Callery, M J Mangino, M W Flye
World Journal of Surgery|January 5, 2008
Risk prediction for development of pancreatic fistula using the ISGPF classification schemeWande B Pratt, Mark P Callery, Charles M Vollmer
Transplantation|May 1, 1991
Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells--a basis of portal venous toleranceM P Callery, M J Mangino, M W Flye
Surgery|December 25, 2007
POSSUM accurately predicts morbidity for pancreatic resectionWande Pratt, Saju Joseph, Mark P Callery, et al.
Surgical Endoscopy|March 26, 2005
The net immunologic advantage of laparoscopic surgeryY W Novitsky, D E M Litwin, M P Callery
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1976
Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acidM D Loberg, M Cooper, E Harvey, et al.
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
Journal of the American College of Surgeons|September 1, 2009
Diagnosis and management of pancreatic pseudocysts: what is the evidence?Jeremy W Cannon, Mark P Callery, Charles M Vollmer
Surgical Oncology|November 24, 2001
Ubiquitin proteasome pathway: implications and advances in cancer therapyS A Shah, M W Potter, M P Callery
Surgery|June 21, 2002
Ubiquitin proteasome inhibition and cancer therapyShimul A Shah, Michael W Potter, Mark P Callery
Surgical Laparoscopy & Endoscopy|April 1, 1996
Strangulated incisional hernia at trocar siteD B Jones, M P Callery, N J Soper
Surgery|August 1, 1991
A biologic basis for limited Kupffer cell reactivity to portal-derived endotoxinM P Callery, M J Mangino, M W Flye
World Journal of Surgery|January 5, 2008
Risk prediction for development of pancreatic fistula using the ISGPF classification schemeWande B Pratt, Mark P Callery, Charles M Vollmer
Transplantation|May 1, 1991
Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells--a basis of portal venous toleranceM P Callery, M J Mangino, M W Flye
Surgery|December 25, 2007
POSSUM accurately predicts morbidity for pancreatic resectionWande Pratt, Saju Joseph, Mark P Callery, et al.
Surgical Endoscopy|March 26, 2005
The net immunologic advantage of laparoscopic surgeryY W Novitsky, D E M Litwin, M P Callery
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1976
Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acidM D Loberg, M Cooper, E Harvey, et al.
Pageof 22